Cytiva

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Merck Announces €121 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin, USA

Wednesday, December 29, 2021

Merck a leading science and technology company today announced that its Life Science business sector has been awarded a million contract award for the construction of a lateral flow membrane production facility over a threeyear period at the company...

Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings

Wednesday, December 29, 2021

Oramed Pharmaceuticals Inc a clinicalstage pharmaceutical company focused on the development of oral drug delivery platforms today announced that its subsidiary Oravax Medical has signed a Cooperation and Purchase Agreement with Vietnambased Tan Than...

Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use

Wednesday, December 29, 2021

Aditxt Inc a biotech innovation company with a mission to improve the health of the immune system today announced it had signed an amendment to its February Exclusive License Agreement with Stanford University extending Aditxts exclusive right to l...

Aditxt Signs Share Exchange Agreement to Acquire AiPharma

Tuesday, December 28, 2021

Aditxt Inc a biotech innovation company with a mission to improve the health of the immune system has signed a share exchange agreement to acquire AiPharma Global Holdings LLC a whollyowned subsidiary of AiPharma Group Ltd AiPharma The share exchange...

Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML

Monday, December 27, 2021

Celularity Inc a clinicalstage biotechnology company developing placentalderived allogeneic cell therapies today announced the US Food and Drug Administration FDA has granted Fast Track Designation for its nongenetically modified cryopreserved human...

Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China

Monday, December 27, 2021

Sutro Biopharma Inc a clinicalstage drug discovery development and manufacturing company focused on the application of precise protein engineering and rational design to create nextgeneration cancer and autoimmune therapeutics today announced an excl...

Regor Therapeutics Announces U.S. FDA Authorization to Conduct Regor's First-in-Human Clinical Trial with the Next Generation Targeted Inhibitor RGT-419B for Oncology

Monday, December 27, 2021

Regor Therapeutics a clinicalstage biotech company announced authorization from the US Food and Drug Administration FDA to proceed with Regors Phase clinical development plans for RGTB RGTB is a new generation CDK small molecule inhibitor with an op...

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan

Friday, December 24, 2021

Merck known as MSD outside the United States and Canada and Ridgeback Biotherapeutics today announced that Japans Ministry of Health Labor and Welfare has granted Special Approval for Emergency in Japan for molnupiravir an investigational oral antivi...

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences

Thursday, December 23, 2021

Sosei Group Corporation announces that in connection with the Collaboration and License Agreement License Agreement with Neurocrine Biosciences Inc Neurocrine Biosciences announced November the applicable waiting period under the HartScottRodino An...

Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

Thursday, December 23, 2021

Merck known as MSD outside the United States and Canada and Ridgeback Biotherapeutics today announced that the US Food and Drug Administration FDA has granted Emergency Use Authorization EUA for molnupiravir an investigational oral antiviral MK EIDD...